FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
The U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
Like
Be the first to like this
WORC Update
(He/Him)
Head of community, WORC.Community (A Caterpillar Hill Limited venture).
Thank you for joining us here at WORC! This platform has the sole purpose of bringing Organoid and Organ-on-a-chip researchers together! Easily connect, share content, ideas and experiences in this transformative area of science. The idea for this community came after speaking with many of you expressing the need for joined up thinking and making long lasting connections.
